ACAN and cancer: Some other proteoglycans such as aggrecan, neurocan, brevican, biglycan, lumican, glypicans, fibromodulin, agrin, collagen XVIII, NG2, and serglycin are also involved in cancer progression, but their expression and functional role have not yet been investigated in prostate cancer.